Updated: May 19, 2026

Elizabeth H.Z. Thompson

ACADACADIA PHARMACEUTICALS INCSEC CIK: 0001861477
Estimated Net Worth
$6.46 Million
Last Updated: May 19, 2026 11:51 PM EST

Transaction Summary

Total Transactions26
Buy-Sell Ratio0.00
Buy Transactions0
Sell Transactions5

Transaction Volume

Total Volume-$2.33M
Net Volume$2.33M
Buy Volume$0.00
Sell Volume-$2.33M

Trade Analysis

AVG Trade Size-$246.05K
Largest Trade$0.00
Most Active MonthMar
Most Active Year2024

Trading Sentiment

OverallBullish
Recent TradeSelling
Last 90 Days-1 Trades
ConvictionMedium

Net Worth & Trading Activity Over Time

Loading...

Monthly Trading Pattern

Loading...

Past Insider Trading and Trends

Elizabeth H.Z. Thompson has an estimated net worth of $6.46 Million. This is based on reported shares across multiple companies, which include Horizon Therapeutics Public Ltd Co, IGM Biosciences, Inc., and ACADIA PHARMACEUTICALS INC.



2024 was Elizabeth H.Z. Thompson's most active year for acquiring shares with 7 total transactions. Elizabeth H.Z. Thompson's most active month to acquire stocks was the month of February. 2022 was Elizabeth H.Z. Thompson's most active year for disposing of shares, totalling 13 transactions. Elizabeth H.Z. Thompson's most active month to dispose stocks was the month of September. 2024 saw Elizabeth H.Z. Thompson paying a total of $0.00 for 424,334 shares, this is the most they've acquired in one year. In 2023 Elizabeth H.Z. Thompson cashed out on 115,474 shares for a total of $1,697,987.50, their largest year based on trade value.

Holdings & Transactions

ACADacadia pharmaceuticals inc
EVP, Head Research & Dev
Updated: Mar 26, 2026VIEW QUOTE
Form TypeSEC Filing
-0.133.44K$21.47-$73.75K23.43KMar 24 - 25View
131.12K131.12KMar 06View
118.26K118.26KMar 24View
389.13K389.13KAug 12View
View
IGMSigm biosciences, inc.
Updated: Aug 14, 2025VIEW QUOTE
Form TypeSEC Filing
-1.007.20KAug 14View
0.11694.007.20KJun 30View
0.12694.006.50KMar 31View
0.331.45K5.81KDec 31View
0.501.45K4.36KSep 30View
1.001.45K2.90KJun 28View
1.45K1.45KMar 29View
29.40K29.40KMar 12View
31.00K31.00KOct 03View
View
horizon therapeutics public ltd co
EVP, Research & Development Officer
Updated: Oct 06, 2023
Form TypeSEC Filing
-1.00113.47K$116.50-$1.70MOct 06View
-0.122.00K14.58KMar 13View
20.70K20.70KJan 04View
-0.279.45K$113.80-$1.08M35.52KDec 30View
-0.466.01K$85.00-$510.60K6.97KScheduledJul 19 - 20View
-0.0182.00$85.01-$6.97K12.98KScheduledJul 07View
-0.388.10K$115.64-$936.45K13.06KScheduledApr 18View
0.4814.39K$101.84-$715.94K59.15KJan 04 - 05View
-0.357.54K$106.34-$802.02K14.19KAug 05View
-0.225.99K$96.59-$578.38K21.73KJul 01View
15.64KView